NCT04392674 is a NA clinical trial of the new tissue containment system in Gynecologic Surgery, sponsored by Jing Liang.

Who is sponsoring NCT04392674?

NCT04392674 is sponsored by Jing Liang.

What drugs are being tested in NCT04392674?

Interventions in NCT04392674: the new tissue containment system.

What condition does NCT04392674 study?

NCT04392674 studies Gynecologic Surgery.

Is NCT04392674 still recruiting?

NCT04392674 is currently status unknown. Last updated 26 October 2022.

Last reviewed 2022-10-26 · How we verify

NCT04392674

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Safety and Efficacy of Using the New Tissue Containment System During Laparoscopic Myomectomy Morcellation

Status unknown NA Last updated 26 October 2022

What this trial tests

NA trial testing the new tissue containment system in Gynecologic Surgery in 400 participants. Status unknown.

Timeline

20 May 2020

Primary endpoint
1 December 2022

20 December 2022

Quick facts

Lead sponsor	Jing Liang
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	400
Start date	20 May 2020
Primary completion	1 December 2022
Estimated completion	20 December 2022
Sites	1 location across China

Drugs / interventions tested

the new tissue containment system

Conditions studied

Gynecologic Surgery — all drugs for Gynecologic Surgery →

Sponsor

Jing Liang

Who can join

Adults 18 to 45, female only, with Gynecologic Surgery. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study is designed to evaluate the safety of performing the new tissue containment system during laparoscopic myomectomy morcellation. Pre- and perimenopausal women, aged 18-45 undergoing laparoscopic myomectomy morcellation

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of the new tissue containment system

Trials testing the same drug.

NCT04423172 — Safety, Efficacy and Operability of Using the New Tissue Containment System During Laprascopic Hysterectomy · NA · unknown

Other recruiting trials for Gynecologic Surgery

Currently open trials in the same condition.

NCT07114965 — Effects Of Quadratus Lumborum Type 1 Block And Transversalis Facial Plane Block On Acute Pain In Gynecological Surgery · active not recruiting
NCT05526534 — A RCT on the Preventive Effect of HFNC on Postoperative Pulmonary Complications in Patients With Gynecologic Neoplasms · NA · recruiting
NCT05071976 — A Study of Near-Infrared Fluorescence Imaging With ICG During Reconstructive Gynecologic Surgery · NA · active not recruiting

Other Jing Liang trials

Trials by the same sponsor.

NCT04613219 — Correlation Between the Change of Peripheral Lymphocyte Subsets and Clinically Amyopathic Dermatomyositis Combined With · unknown
NCT04423172 — Safety, Efficacy and Operability of Using the New Tissue Containment System During Laprascopic Hysterectomy · NA · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04392674 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Jing Liang
Last refreshed: 26 October 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04392674.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing